22:45 , Sep 6, 2018 |  BC Extra  |  Company News

Management tracks: Rheos, Aileron

Immunometabolism company Rheos Medicines Inc. (Cambridge, Mass.) hired Sanjay Keswani as CEO. He was SVP and global head of neuroscience, ophthalmology and rare disease for the Pharma Research and Early Development (pRED) group at Roche...
16:52 , Aug 15, 2018 |  BC Extra  |  Financial News

Third Rock names Kafka venture partner

Third Rock Ventures named Steve Kafka venture partner. He was president and COO at cancer genomics company Foundation Medicine Inc., which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Prior to that, he was COO and CFO at stapled...
22:04 , Aug 14, 2018 |  BC Extra  |  Company News

Management tracks: Cheng departing Gilead as CMO

Gilead Sciences Inc. (NASDAQ:GILD) said CMO Andrew Cheng will leave the company, effective Sept. 7, after five months in the role to pursue another opportunity. Gilead did not say who would replace Cheng, who joined...
22:57 , May 16, 2018 |  BC Extra  |  Company News

Management tracks: Novartis, Aileron

Novartis AG (NYSE:NVS; SIX:NOVN) said General Counsel Felix Ehrat will retire, effective June 1, in light of Novartis' payments to a consultancy owned by Michael Cohen. "As a co-signatory with our former CEO, I take...
00:30 , Oct 12, 2017 |  BC Innovations  |  Product R&D

Artificial mini proteins

Virvio Inc. has spun out of a group from the University of Washington to develop artificial mini proteins as novel influenza therapeutics. The mini proteins, typically ranging between 30 and 50 amino acids in length,...
22:43 , Jul 7, 2017 |  BioCentury  |  Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the continued...
20:20 , Jul 7, 2017 |  BC Week In Review  |  Financial News

Aileron raises $56.3M in IPO

On June 28, oncology play Aileron Therapeutics Inc. (NASDAQ:ALRN) raised $56.3 million through the sale of 3.8 million shares at $15 in an IPO underwritten by BofA Merrill Lynch, Jefferies, William Blair and Canaccord. Aileron Therapeutics...
22:43 , Jun 29, 2017 |  BC Extra  |  Financial News

Dova rises, Aileron sinks after NASDAQ listings

Rare disease company Dova Pharmaceuticals Inc. (NASDAQ:DOVA) and oncology play Aileron Therapeutics Inc. (NASDAQ:ALRN) each began trading Thursday after pricing IPOs. Dova gained $2.81 (17%) to $19.81 after raising $75.1 million through the sale of 4.4...
00:25 , Jun 21, 2017 |  BC Extra  |  Company News

Management tracks

Biogen Inc. (NASDAQ:BIIB) named Ginger Gregory EVP and chief human resources officer, effective July 17. She was chief human resources officer at Shire plc (LSE:SHP; NASDAQ:SHPG). Neurodegenerative, inflammation and cancer company Active Biotech AB (SSE:ACTI) promoted...
23:34 , Jun 15, 2017 |  BC Innovations  |  Tools & Techniques

Breaking the barrier

A three-way deal between Amgen Inc., Feldan Therapeutics Inc. and Elasmogen Ltd. is the latest cause for optimism that technologies are finally converging to enable the generation of cell-penetrating biologics. The biotechs join a small...